Dr. Bernard R. Gibson, MD

Dr. Gibson practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Gibson's NPI, 1821098724, was assigned on July 21, 2005. Dr. Gibson graduated from UCSF School of Medicine in 1971. Dr. Gibson holds Texas license E1590.

Dr. Gibson's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Gibson's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Gibson to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gibson practices. Vendor and product names are available with a free account.

Dermatology is Dr. Gibson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gibson is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gibson's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and itchy rashes among the conditions Dr. Gibson treats.

CMS data shows 2,485 Medicare services from Dr. Gibson across 14 procedure codes in 2024, for 552 Medicare patients. Medicare paid $60,730 for them.

CMS counts 552 Medicare patients who saw Dr. Gibson in 2024. The largest group is 65 to 74, with 260 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gibson's median patient age at 73, with 48% women.

In 2024, Dr. Gibson wrote 257 Medicare Part D claims for 92 patients. 84% of them were for generic drugs. CMS names the drug for 141 of them, across 7 drugs with 11 or more claims each, at $75,204 in total drug cost. In 2023, CMS named 51 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Gibson for performance year 2024, reported as part of a group. Dr. Gibson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 631 procedures of removal of skin lesions by Dr. Gibson, more than 89% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Gibson, published from 2010 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Skin. Dr. Gibson's most frequent co-authors are Brent Christopher Kelly, MD, Michael George Wilkerson, MD and Paige Elizabeth Hoyer, MD.

CMS Open Payments shows 5 general payments to Dr. Gibson from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $45.

Dmand AI lists 2 awards for Dr. Gibson, most recently CMS Stage 1 EHR in 2013.

Dr. Gibson graduated from UCSF School of Medicine in 1971. Dr. Gibson is a member of AAD.

Dr. Gibson is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.